Brief: Hemcheck Sweden Further Extends Subscription Period In Deal With Bio Vitos
Aug 24 (Reuters) - Hemcheck Sweden AB HEMC.ST :
* FURTHER EXTENDS THE SUBSCRIPTION PERIOD IN THE DEAL WITH BIO VITOS
* FINAL DECISION FROM NASDAQ HAS NOT YET BEEN RECEIVED
* SUBSCRIPTION PERIOD IN DEAL WITH BIO VITOS IS EXTENDED UNTIL 30 SEPTEMBER 2023
Source text for Eikon: ID:nWkr90DMjd
Further company coverage: HEMC.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Bio Vitos Pharma AB
See all newsAdvisory: Alerts on Bio Vitos Pharma withdrawn
Brief: Bio Vitos Pharma Q4 Operating Revenue Falls To SEK 0.3 Mln
Brief: Bio Vitos Reaches Settlement With Norvolt AS, Norvolt Capital AS
Brief: Bio Vitos Pharma Appoints Sven Rohmann As Acting CEO
Brief: Bio Vitos Pharma Q3 Loss After Financial Items SEK 3.0 Mln